Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older
Clinical trial NCT04405076 · COMPLETED
Trial details
- NCT number
- NCT04405076
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-29
- Primary completion
- 2021-10-28
- Enrollment
- 660
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.